Fig. 1.
Fig. 1. Induction of FBG γ chain mRNA expression in HepG2 and A549 cells. HepG2 (lanes 1-4) and A549 (lanes 6-9) cells were treated as follows: lanes 1 and 6, no treatment; lanes 2 and 7, 0.1 μmol/L DEX; lanes 3 and 8, 25 U/mL IL-6; lanes 4 and 9, 0.1 μmol/L DEX + 25 U/mL IL-6. (A) Northern blot of 30 μg total RNA from HepG2 or A549 cells, or 5 μg human liver poly(A)+ mRNA (lane 5) probed with 32P-labeled human FBG γ chain cDNA. (B) Duplicate gel of RNA samples stained with acridine orange to confirm the integrity and amount of each RNA sample loaded. Arrowheads mark the 28S and 18S rRNAs.

Induction of FBG γ chain mRNA expression in HepG2 and A549 cells. HepG2 (lanes 1-4) and A549 (lanes 6-9) cells were treated as follows: lanes 1 and 6, no treatment; lanes 2 and 7, 0.1 μmol/L DEX; lanes 3 and 8, 25 U/mL IL-6; lanes 4 and 9, 0.1 μmol/L DEX + 25 U/mL IL-6. (A) Northern blot of 30 μg total RNA from HepG2 or A549 cells, or 5 μg human liver poly(A)+ mRNA (lane 5) probed with 32P-labeled human FBG γ chain cDNA. (B) Duplicate gel of RNA samples stained with acridine orange to confirm the integrity and amount of each RNA sample loaded. Arrowheads mark the 28S and 18S rRNAs.

Close Modal

or Create an Account

Close Modal
Close Modal